CYTK
#906
Cytokinetics, Incorporated - Common Stock
82.2 4 USD
-0.03%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.10%
Monthly Change
+17.23%
6 month change
+27.66%
Year Change
+41.55%
Previous Close
84.8 7
Open
82.2 4
Low
82.2 4
High
82.2 4
Volume
131
Financials
- Market Capitalization 10.23 B
- Employee 673
- Founded 1997
- CEO Robert I. BlumRobert I. Blum
- Website www.cytokinetics.com
- Headquarter California, United States
- FIGI BBG000F0R4N9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-9.62
Price to sales ratio
0.07
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 881 |  ABVX Abivax SA - American Depositary Shares | 135.98 USD | -2.80% | -4.58% | +36.53% | +1410.89% | 10.68 B USD | ||
| 893 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 74.11 USD | -3.00% | -14.62% | -0.59% | +89.54% | 10.44 B USD | ||
| 924 |  NUVL Nuvalent, Inc. - Class A Common Stock | 123.94 USD | +0.03% | +0.19% | +0.52% | +30.53% | 9.79 B USD | ||
| 948 |  IONS Ionis Pharmaceuticals, Inc. - Common Stock | 56.75 USD | -2.58% | -32.78% | -22.78% | -21.32% | 9.38 B USD |
Frequently asked questions about Cytokinetics, Incorporated - Common Stock
What is the Cytokinetics, Incorporated - Common Stock stock price today?
The current price of Cytokinetics, Incorporated - Common Stock (CYTK) is 82.24. Over the past 24 hours, the stock has changed by -3.10%. Follow the CYTK chart for real-time price dynamics.
What is the stock ticker of Cytokinetics, Incorporated - Common Stock?
Cytokinetics, Incorporated - Common Stock trades under the ticker CYTK. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cytokinetics, Incorporated - Common Stock stock going up?
CYTK has changed by -4.47% over the last week, +17.23% over the last month, and +41.55% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Cytokinetics, Incorporated - Common Stock net income for the last quarter?
Cytokinetics, Incorporated - Common Stock reported net income of -206.03 M for the last quarter. The previous quarter showed -183.03 M, which means net income changed by -12.57%.
How many employees does Cytokinetics, Incorporated - Common Stock have?
As of the latest available data, Cytokinetics, Incorporated - Common Stock has 673 employees. Workforce size can provide additional context about the company's scale and operations.
What is Cytokinetics, Incorporated - Common Stock EBITDA?
Cytokinetics, Incorporated - Common Stock EBITDA is -180.24 M, and its EBITDA margin is -931.23%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Cytokinetics, Incorporated - Common Stock stock?
You can buy Cytokinetics, Incorporated - Common Stock (CYTK) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cytokinetics, Incorporated - Common Stock stock?
Investing in Cytokinetics, Incorporated - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CYTK chart and related analysis on metatrader.com as part of your research.